Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate

Breast

Volumn 13, Issue 4, 2004, Pages 321-324

  Zaucha, R ^a   Sosinska Mielcarek K ^a   Jassem, J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Breast cancer; Liver metastases; Long term survival; Medroxyprogesterone acetate

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN;

AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DRUG RESPONSE; FEMALE; HUMAN; LIVER METASTASIS; MASTECTOMY; MOBILIZATION; MULTIPLE CANCER; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SURVIVAL TIME; TREATMENT OUTCOME; VISCERAL METASTASIS;

EID: 4444252952     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2004.05.003     Document Type: Article

References (28)

1. Greenberg P.A. Hortobagyi G.N. Smith T.L. Ziegler L.D. Frye D.K. Buzdar A.U. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer J Clin Oncol 14 1996 2197-2205
2. Hortobagyi G.N. Can we cure limited metastatic breast cancer? J Clin Oncol 20 2002 620-623
3. Pierga J.Y. Robain M. Jouve M. et al. Response to chemotherapy is a major parameter influencing long-term survival of metastatic breast cancer patients Ann Oncol 12 2001 231-237
4. Zinser J.W. Hortobagyi G.N. Buzdar A.U. Smith T.L. Fraschini G. Clinical course of breast cancer patients with liver metastases J Clin Oncol 5 1987 773-782
5. O'Shaughnessy J. Twelves C. Aapro M. Treatment for anthracycline-pretreated metastatic breast cancer Oncologist 7 Suppl 6 2002 4-12
6. Ryberg M. Nielsen D. Osterlind K. Skovsgaard T. Dombernowsky P. Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy Ann Oncol 12 2001 81-87
7. Jassem J. Pienkowski T. Pluzanska A. et al. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial J Clin Oncol 19 2001 1707-1715
8. Fossati R. Confalonieri C. Torri V. et al. Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women J Clin Oncol 16 1998 3439-3460
9. Jardines L. Callans L.S. Torosian M.H. Recurrent breast cancer: presentation, diagnosis, and treatment Semin Oncol 20 1993 538-547
10. Selzner M. Morse M.A. Vredenburgh J.J. Meyers W.C. Clavien P.A. Liver metastases from breast cancer: long-term survival after curative resection Surgery 127 2000 383-389
11. Schneebaum S. Walker M.J. Young D. Farrar W.B. Minton J.P. The regional treatment of liver metastases from breast cancer J Surg Oncol 55 1994 26-31
12. Carlini M. Lonardo M.T. Carboni F. et al. Liver metastases from breast cancer. Results of surgical resection Hepatogastroenterology 49 2002 1597-1601
13. Maksan S.M. Lehnert T. Bastert G. Herfarth C. Curative liver resection for metastatic breast cancer Eur J Surg Oncol 26 2000 209-212
14. Tekin K. Kocaoglu H. Bayar S. Long-term survival after regional chemotherapy for liver metastases from breast cancer. A case report Tumori 88 2002 167-169
15. Parazzini F. Colli E. Scatigna M. Tozzi L. Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials Oncology 50 1993 483-489
16. Bentel J.M. Birrell S.N. Pickering M.A. Holds D.J. Horsfall D.J. Tilley W.D. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells Mol Cell Endocrinol 154 1999 11-20
17. Hackenberg R. Hawighorst T. Filmer A. Nia A.H. Schulz K.D. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor Breast Cancer Res Treat 25 1993 217-224
18. Davila E. Vogel C.L. East D. Cairns V. Hilsenbeck S. Clinical trial of high-dose oral medroxyprogesterone acetate in the treatment of metastatic breast cancer and review of the literature Cancer 61 1988 2161-2167
19. Cavalli F. Goldhirsch A. Jungi F. Martz G. Mermillod B. Alberto P. Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer J Clin Oncol 2 1984 414-419
20. Toyama T. Yamashita H. Hara Y. Hikosaka Y. Kobayashi S. Iwase H. Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment Int J Clin Oncol 6 2001 306-309
21. Tominaga T. Abe O. Ohshima A. et al. Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer Eur J Cancer 30A 1994 959-964
22. Nishimura R. Nagao K. Matsuda M. et al. Benefits of medroxyprogesterone acetate (MPA) in advanced or recurrent breast cancer with higher serum concentration Breast Cancer 2 1995 133-141
23. Mauriac L. Pippen J.E. Quaresma Albano J. Gertler S.Z. Osborne C.K. Fulvestrant (Faslodex) versus anastrozole for the second-line treatment of advanced breast cancer in subgroups of postmenopausal women with visceral and non-visceral metastases: combined results from two multicentre trials Eur J Cancer 39 2003 1228-1233
24. Nabholtz J.M. Mackey J.R. Smylie M. et al. Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer J Clin Oncol 19 2001 314-321
25. Nabholtz J.M. Reese D.M. Third-generation aromatase inhibitors in the treatment of advanced breast cancer Breast Cancer 8 2001 305-309
26. Nabholtz J.M. Riva A. Taxane/anthracycline combinations: setting a new standard in breast cancer? Oncologist 6 Suppl 3 2001 5-12
27. Naomoto Y. Sadamori H. Matsukawa H. et al. Multiple liver metastases of breast cancer: report of a case successfully treated with hormone-cytokine-chemotherapy Jpn J Clin Oncol 29 1999 390-394
28. Wilson J.M. Carder P. Downey S. Davies M.H. Wyatt J.I. Brennan T.G. Treatment of metastatic breast cancer with liver transplantation Breast J 9 2003 126-128